In one paragraphArticle in Nature chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.2field-weighted citation impact, top 38% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
5 · Who and what moneyAuthors and funding
8 authors at 2 institutions in 1 country.
Chang-Ki OhDepartments of Molecular Medicine and Neuroscience, Neurodegeneration New Medicines Center, The Scripps Research Institute, La Jolla, CA, USA.ORCID 0000-0003-2489-4072 Juan Piña-CrespoDepartments of Molecular Medicine and Neuroscience, Neurodegeneration New Medicines Center, The Scripps Research Institute, La Jolla, CA, USA.
Maria TalantovaDepartments of Molecular Medicine and Neuroscience, Neurodegeneration New Medicines Center, The Scripps Research Institute, La Jolla, CA, USA.
Lauren N CarnevaleDepartments of Molecular Medicine and Neuroscience, Neurodegeneration New Medicines Center, The Scripps Research Institute, La Jolla, CA, USA.ORCID 0000-0003-0451-0481 Mary LewinskiDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
John GuatelliDepartment of Medicine, University of California, San Diego, La Jolla, CA, USA.
Stuart A LiptonDepartments of Molecular Medicine and Neuroscience, Neurodegeneration New Medicines Center, The Scripps Research Institute, La Jolla, CA, USA. slipton@scripps.edu.ORCID 0000-0002-3490-1259 Scripps Research Institute · USUniversity of California San Diego · US
Funding
Novel Proteomics Approach to HIV-Associated Neurocognitive Disorder & Drug AbuseDP1DA041722 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI LIPTON, STUART A · 2016 to 2020
$7.0MLeadership in AD/ADRD Drug DiscoveryR35AG071734 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI LIPTON, STUART A · 2021 to 2025
$5.4MOmics Analyses of HIV and Substance Use DisorderR01DA048882 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI REPUNTE-CANONIGO, VEZ · 2019 to 2023
$4.3MDynamic Interactions of the S-Nitrosoproteome in Type 2 Diabetes/Metabolic Syndrome and Alzheimer’s DiseaseRF1AG057409 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI LIPTON, STUART A · 2017 to 2020
$4.1MS-Nitrosylation-Induced Posttranslational Modification and Aberrant Cell Signaling in Sporadic Alzheimer's DiseaseR01AG056259 · NIA · SCRIPPS RESEARCH INSTITUTE, THE · PI LIPTON, STUART A · 2017 to 2021
$3.3MNIA NIH HHS R01 AG056259NIA NIH HHS R35 AG071734NIA NIH HHS RF1 AG057409NIDA NIH HHS DP1 DA041722NIDA NIH HHS R01 DA048882
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
Biochemical PhenomenaCOVID-19Angiotensin-Converting Enzyme 2HumansProtein BindingSARS-CoV-2Angiotensin-Converting Enzyme 2
Identifiers
PMID37798355
PMCPMC12186665
OpenAlexW4387363907
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390